AMH and ovarian reserve: what the numbers do and do not tell you

Few numbers in fertility care get searched, screenshotted and worried over as much as AMH. People arrive at consultations already knowing their value and already having decided what it means, usually from a forum.

It is a genuinely useful test. It is also widely misread, and the misreading runs in one direction: people treat it as a verdict on whether they can have a child, when it is closer to a planning instrument.

What AMH is measuring

Anti-Müllerian hormone is produced by small follicles in the ovaries. Measuring it gives an estimate of how many of those follicles are available — the pool a stimulation cycle would be drawing from.

It is usually read alongside two other things: the antral follicle count, which is a direct count of small follicles visible on an ultrasound, and your age. Those three together give a picture that none gives alone.

Its practical job is prediction of response. A clinic uses it mainly to answer: what starting dose is appropriate, which protocol makes sense, and roughly how many eggs might this cycle produce? Those are exactly the decisions the ESHRE guideline on ovarian stimulation, updated in 2025, addresses.

What it does not measure

It is not a measure of egg quality. Quantity and quality are different properties, and AMH speaks only to the first. This is the single most common misunderstanding, and it is why age matters independently: two people with the same AMH but ten years between them are not in the same position, because age carries information about quality that AMH does not.

It is not a prediction of whether you can conceive. AMH predicts how ovaries respond to stimulation. Plenty of people with low values conceive, with treatment and without it. It is a poor tool for the question most people are actually asking it.

It is not a countdown. A single value is a snapshot, and it does not tell you how much time you have or when menopause will arrive. It can also vary between laboratories and between assays, which is why comparing your number to someone else’s — or to your own from a different lab — is less meaningful than it looks.

It is not the whole workup. Tubes, uterus, sperm and cycle history all matter, and a plan built on one hormone while ignoring the rest is not a plan.

If your number is lower than you hoped

This is the situation that sends people into a spiral, so it is worth being plain about what it does and does not change.

What it does change: likely response to stimulation, and therefore protocol, dose, and expectations about how many eggs a cycle produces. It may make your clinic suggest planning for more than one retrieval, which is a scheduling and budgeting fact rather than a judgement.

What it does not change: that you are a candidate for treatment, that the cycle is worth designing carefully, or that the rest of your picture matters. A low AMH is a reason for a specific plan, not a reason to conclude anything about the outcome.

It is also a reason to ask about sequence rather than to hurry blindly. If more than one retrieval is likely, knowing that now shapes travel, cost and timing in a way that is much easier to handle deliberately than discovered halfway through.

If your number is high

A high AMH usually means a strong response to stimulation, which is a good starting position and also the situation where clinics pay closest attention to dosing. It is a common finding in polycystic ovary syndrome, and what it means for how a cycle is designed and monitored is covered in PCOS and IVF.

What to ask your clinic

• How are you reading this alongside my antral follicle count and my age?
• What does it suggest about protocol and starting dose for me?
• Roughly what response are you expecting, and what would surprise you?
• Does this change how many attempts we should plan for?
• What else in my workup matters as much or more?

That last question is the useful corrective. Most treatment plans are shaped by several findings together, and asking which ones your doctor is weighting tells you far more than any single value.

The habit worth building

Whenever a number arrives, ask what decision it changes. If the answer is “it changes the dose and the protocol”, that is a planning input and you can treat it as one. If the answer is “nothing yet”, it is context.

Applied to results generally, that habit is the difference between reading your file and worrying about it — the same discipline that makes clinic success rates legible, which we looked at in what IVF success rates really mean.

This article is general information, not medical advice. What your results mean for you is a question for the doctor who has your full workup.

For how testing fits into the wider process, read the patient journey.